Clinical Trials Directory

Trials / Unknown

UnknownNCT06174259

Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients

Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients: a Prospective Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
Menoufia University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Breast cancer is the most common cancer type among women in Egypt and world. Preclinical studies show fasting reduces growth factors and modulates nutrient sensing systems, protecting normal cells against chemotherapy. However, cancer cells are not protected due to Differential Stress Resistance (DSR), making them more vulnerable to chemotherapeutics. This study aims to evaluate intermittent fasting impact on neoadjuvant chemotherapy in breast cancer patients.

Conditions

Interventions

TypeNameDescription
OTHERintermittent fasting16/8 intermittent fasting (limiting foods and calorie-containing beverages to a set window of 8 hours per day)

Timeline

Start date
2023-06-01
Primary completion
2024-06-01
Completion
2025-06-01
First posted
2023-12-18
Last updated
2024-02-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06174259. Inclusion in this directory is not an endorsement.